RANDOMIZED, CONTROLLED, PHASE 2 TRIAL OF TYPE 1 IFN INHIBITOR ANIFROLUMAB IN PATIENTS WITH ACTIVE PROLIFERATIVE LUPUS NEPHRITIS

被引：12
|
作者：
Jayne, D. [1 ]
Rovin, B. H. [2 ]
Mysler, E. [3 ]
Furie, R. [4 ]
Houssiau, F. [5 ,6 ]
Trasieva, T. [7 ]
Knagenhjelm, J. [7 ]
Schwetje, E. [8 ]
Chia, Y. L. [9 ]
Tummala, R.
Lindholm, C. [7 ]
机构：
[1] Univ Cambridge, Dept Med, Cambridge, England
[2] Ohio State Univ, Dept Internal Med Nephrol, Columbus, OH 43210 USA
[3] Org Med Invest, Rheumatol, Buenos Aires, DF, Argentina
[4] Zucker Sch Med Hofstra Northwell, Div Rheumatol, Great Neck, NY USA
[5] Clin Univ St Luc, Brussels, Belgium
[6] Catholic Univ Louvain, Inst Rech Expt & Clin, Serv Rhumatol, Brussels, Belgium
[7] AstraZeneca, BioPharmaceut R&D, Gothenburg, Sweden
[8] AstraZeneca, BioPharmaceut R&D, Gaithersburg, MD USA
[9] AstraZeneca, BioPharmaceut R&D, San Francisco, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷
关键词：
D O I：
10.1136/annrheumdis-2021-eular.1605
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0690
引用
收藏
页码：592 / 592
页数：1
相关论文
共 50 条
  • [1] Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritis
    Jayne, David
    Rovin, Brad
    Mysler, Eduardo F.
    Furie, Richard A.
    Houssiau, Frederic A.
    Trasieva, Teodora
    Knagenhjelm, Jacob
    Schwetje, Erik
    Chia, Yen Lin
    Tummala, Raj
    Lindholm, Catharina
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (04) : 496 - 506
  • [2] Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1) a randomised, controlled, phase 3 trial
    Furie, Richard A.
    Morand, Eric F.
    Bruce, Ian N.
    Manzi, Susan
    Kalunian, Kenneth C.
    Vital, Edward M.
    Ford, Theresa Lawrence
    Gupta, Ramesh
    Hiepe, Falk
    Santiago, Mittermayer
    Brohawn, Philip Z.
    Berglind, Anna
    Tummala, Raj
    [J]. LANCET RHEUMATOLOGY, 2019, 1 (04): : E208 - E219
  • [3] A Phase 3 Randomized Controlled Trial of Anifrolumab in Patients with Moderate to Severe Systemic Lupus Erythematosus
    Furie, Richard
    Morand, Eric
    Bruce, Ian
    Manzi, Susan
    Kalunian, Kenneth
    Vital, Edward
    Lawrence-Ford, Theresa
    Gupta, Ramesh
    Hiepe, Falk
    Santiago, Mittermayer
    Brohawn, Philip
    Berglind, Anna
    Tummala, Raj
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [4] Randomized controlled trial of pulse synchronization cyclophosphamide apheresis for proliferative lupus nephritis
    Wallace, DJ
    Goldfinger, D
    Pepkowitz, SH
    Fichman, M
    Metzger, AL
    Schroeder, JO
    Euler, HH
    [J]. JOURNAL OF CLINICAL APHERESIS, 1998, 13 (04) : 163 - 166
  • [5] Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial
    Grootscholten, C.
    Ligtenberg, G.
    Hagen, E. C.
    van den Wall Bake, A. W. L.
    de Glas-Vos, J. W.
    Bijl, M.
    Assmann, K. J.
    Bruijn, J. A.
    Weening, J. J.
    van Houwelingen, H. C.
    Derksen, R. H. W. M.
    Berden, J. H. M.
    [J]. KIDNEY INTERNATIONAL, 2006, 70 (04) : 732 - 742
  • [6] ALTERNATIVE RENAL RESPONSE DEFINITIONS IN A RANDOMIZED, CONTROLLED TRIAL OF OBINUTUZUMAB FOR PROLIFERATIVE LUPUS NEPHRITIS
    Amoura, Z.
    Remy, P.
    Quintana Porras, L. F.
    Chiche, L.
    Chauveau, D.
    Roccatello, D.
    Furie, R.
    Schindler, T.
    Garg, J.
    Cascino, M. D.
    Rovin, B. H.
    Doria, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 104 - 105
  • [7] Alternative Renal Response Definitions in a Randomized, Controlled Trial of Obinutuzumab for Proliferative Lupus Nephritis
    Amoura, Zahir
    Remy, Philippe
    Quintana Porras, Luis Fernando
    Chiche, Laurent
    Chauveau, Dominique
    Roccatello, Dario
    Furie, Richard
    Schindler, Thomas
    Garg, Jay
    Cascino, Matthew
    Rovin, Brad
    Doria, Andrea
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [8] Comparison of Two Steroid Regimens in Induction Therapy of Proliferative Lupus Nephritis: A Randomized Controlled Trial
    Bharati, Joyita
    Rathi, Manish
    Ramachandran, Raja
    Sharma, Aman
    Kumar, Vivek
    Kohli, Harbir Singh
    Gupta, Krishan Lal
    [J]. INDIAN JOURNAL OF NEPHROLOGY, 2019, 29 (05) : 373 - +
  • [9] EFFICACY AND SAFETY OF ANIFROLUMAB IN PATIENTS WITH MODERATE TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF THE SECOND PHASE 3 RANDOMIZED CONTROLLED TRIAL
    Morand, Eric F.
    Furie, Richard
    Tanaka, Yoshiya
    Bruce, Ian N.
    Askanase, Anca D.
    Richez, Christophe
    Bae, Sang-Cheol
    Brohawn, Mr Philip Z.
    Pineda, Lilia
    Berglind, Anna
    Tummala, Raj
    [J]. INTERNAL MEDICINE JOURNAL, 2020, 50 : 22 - 23
  • [10] EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL
    Hassanien, M.
    Moshrif, A.
    Hetta, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 34 - 35
12345